NovaBay Pharmaceuticals, Inc. (NBY)
Total Valuation
NBY has a market cap or net worth of $1.77 million. The enterprise value is -$36,564.
Market Cap | 1.77M |
Enterprise Value | -36,564 |
Important Dates
The last earnings date was Thursday, May 11, 2023, after market close.
Earnings Date | May 11, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
NBY has 2.73 million shares outstanding. The number of shares has increased by 42.21% in one year.
Shares Outstanding | 2.73M |
Shares Change (YoY) | +42.21% |
Shares Change (QoQ) | +7.30% |
Owned by Insiders (%) | 14.60% |
Owned by Institutions (%) | 8.92% |
Float | 2.31M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.13 |
Forward PS | 0.09 |
PB Ratio | 0.19 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.22.
Current Ratio | 2.24 |
Quick Ratio | 1.26 |
Debt / Equity | 0.22 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -146.10% and return on invested capital (ROIC) is -185.30%.
Return on Equity (ROE) | -146.10% |
Return on Assets (ROA) | -95.20% |
Return on Capital (ROIC) | -185.30% |
Revenue Per Employee | $470,276 |
Profits Per Employee | -$617,000 |
Employee Count | 29 |
Asset Turnover | 0.73 |
Inventory Turnover | 1.59 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.10% in the last 52 weeks. The beta is 2.73, so NBY's price volatility has been higher than the market average.
Beta (1Y) | 2.73 |
52-Week Price Change | -91.10% |
50-Day Moving Average | 1.25 |
200-Day Moving Average | 2.85 |
Average Volume (30 Days) | 443,980 |
Short Selling Information
The latest short interest is 148,455, so 5.44% of the outstanding shares have been sold short.
Short Interest | 148,455 |
Short Previous Month | 87,016 |
Short % of Shares Out | 5.44% |
Short % of Float | 6.41% |
Short Ratio (days to cover) | 0.42 |
Income Statement
In the last 12 months, NBY had revenue of $13.64 million and -$17.89 million in losses. Loss per share was -$10.60.
Revenue | 13.64M |
Gross Profit | 7.62M |
Operating Income | -13.77M |
Pretax Income | -12.24M |
Net Income | -17.89M |
EBITDA | -11.82M |
EBIT | -12.24M |
Loss Per Share | -$10.60 |
Balance Sheet
The company has $3.75 million in cash and $1.98 million in debt, giving a net cash position of $1.77 million or $0.65 per share.
Cash & Cash Equivalents | 3.75M |
Total Debt | 1.98M |
Net Cash | 1.77M |
Net Cash Per Share | $0.65 |
Equity / Book Value | 8.89M |
Book Value Per Share | 3.26 |
Working Capital | 5.47M |
Cash Flow
In the last 12 months, operating cash flow was -$6.21 million and capital expenditures -$101,000, giving a free cash flow of -$6.31 million.
Operating Cash Flow | -6.21M |
Capital Expenditures | -101,000 |
Free Cash Flow | -6.31M |
FCF Per Share | -$3.10 |
Margins
Gross margin is 55.84%, with operating and profit margins of -100.96% and -131.20%.
Gross Margin | 55.84% |
Operating Margin | -100.96% |
Pretax Margin | -89.72% |
Profit Margin | -131.20% |
EBITDA Margin | -86.69% |
EBIT Margin | -89.72% |
FCF Margin | -46.26% |
Dividends & Yields
NBY does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -1,033.42% |
FCF Yield | -364.38% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -42.21% |
Shareholder Yield | -42.21% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 16, 2022. It was a reverse split with a ratio of 1:35.
Last Split Date | Nov 16, 2022 |
Split Type | Reverse |
Split Ratio | 1:35 |